Skip to main content
. Author manuscript; available in PMC: 2012 Jan 15.
Published in final edited form as: Drug Alcohol Depend. 2010 Sep 15;113(2-3):192–199. doi: 10.1016/j.drugalcdep.2010.07.025

Figure 4.

Figure 4

Proportions of participants with undetectable viral load (<75 copies/ml) by study arm at each assessment point during the 24-week intervention period. Precise estimates available in online supplementary materials.

DOT: directly observed therapy; TAU: treatment as usual